Fingerprint
Dive into the research topics of 'Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Geert D'Haens, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean Frederic Colombel, Silvio Danese, Marla Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julian Panés, Laurent Peyrin-Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song
Research output: Contribution to journal › Article › peer-review